does the acquisition of the Georgetown AZ assay co
Post# of 30027
would be nice if Georgetown threw that in as a kicker to clinch the deal
all kidding aside, I think Risk is seriously on to something good here:
Quote:
"AMBS has cornered the AD Diagnostic Market"